Last reviewed · How we verify
NCT07126717
Acute Effects of Zynamite® S in Cognitive Function and Mood
NA trial testing Placebo in Cognitive Performance in 88 participants. Completed in 9 June 2025.
2 June 2025
Quick facts
| Lead sponsor | Nektium Pharma SL |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 88 |
| Start date | 12 May 2025 |
| Primary completion | 2 June 2025 |
| Estimated completion | 9 June 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Placebo
- Zynamite® S
Conditions studied
- Cognitive Performance — all drugs for Cognitive Performance →
- Mood — all drugs for Mood →
Sponsor
Nektium Pharma SL
Who can join
Adults 18 to 25, any sex, with Cognitive Performance or Mood. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study sought to confirm the cognitive and mood benefits of a standardized soluble mango leaf extract, named as Zynamite® S. A placebo or a single dose of the botanical extract (100 mg) was administered and its acute effects on mental function and mood were evaluated before product intake, at 30 min, 3 h, and 5 h post-ingestion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07126717
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Performance
Currently open trials in the same condition.
- NCT07056634 — The Effects of Nature-Based Activity vs. Indoor Exercise on Cognition, Psychological, and Physiological Health · NA · recruiting
- NCT06489873 — Lutein, Zeaxathin, and Fish Oil Supplementation · NA · recruiting
- NCT06127511 — Peanut Consumption on Cognitive, Weight, and Inflammation · NA · recruiting
- NCT06606925 — Determining Which Regions of the Brain Are Active During Flight Simulation at Separate Timepoints During Training · NA · recruiting
- NCT07070427 — Cognitive-Based Balance Exercises on the Shooting Performance of Archers · NA · active not recruiting
Other Nektium Pharma SL trials
Trials by the same sponsor.
- NCT06463145 — Study of the Anxiolytic Effects of Aframomum Seed Extract in Elderly People · NA · completed
- NCT04381026 — Effects of a New Botanical Extracts Combination on Quality of Life in Menopausal Spanish Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07126717 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nektium Pharma SL
- Last refreshed: 17 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07126717.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing